The new lab at Victoria’s B.C. Cancer Agency is the most innovative lab for T cell therapy development in Canada, and only one of a dozen immunotherapy labs in the world.
Scientists will now begin testing T cell therapy production for clinical trials.
Immunotherapy is an approach that engages the patient’s immune system to effectively eliminate disease. It is one of the most promising ares in cancer research and care.
“Immunotherapy is beginning to have striking, durable effects against many different cancers and we are immensely grateful to the Conconi family and B.C. Cancer Foundation for giving us the tools to bring these new treatments to the clinic,” said Dr. Brad Nelson, head of the Immunotheraphy Research Program.
The Conconi family donated $2-million to the B.C. Cancer Foundation towards the project, which inspired 5,900 donors in B.C. to also give.